Cooperation is a key business element for c-LEcta in developing innovative and efficient biotech solutions to the industry, and the company is always open for new partnerships.

Efficient joining of c-LEcta assets, namely its technology platforms, production capacities, and market implementation skills, with its partner’s strength in, for instance, product development, marketing, sales, and distribution, improves both partners’ business outcome.

c‑LEcta is flexible in defining fair and practical cooperation terms beneficial for both parties and in due respect of the project scope and the individual competence provided by each partner. Exclusivity, proprietary asset contribution, intellectual property ownership, market-risk dealing, and follow-up business opportunities, like product supply, are further factors that shape the overall cooperation setting.

Cooperation Strategy

Despite the uniqueness of each cooperation, c‑LEcta distinguishes long-term strategic alliances, project-focused partnerships, and pure service models as three major cooperation strategy routes. While Fee for Service and Project Partnership often are linked to early development undertakings, Strategic Alliances additionally address market-near development and approval stages. Each route offers our partners the greatest flexibility toward their specific cooperation and development needs, their partnership flexibility, and their market control.

In Strategic Alliances c-LEcta and its partners closely interact in research, development, and implementation of processes and products in a joint long-term target market. Strategic Alliances comprise several development projects and dedicated teams working on the pipeline progression. Mutual exclusive commitment to the business segment and a clear responsibility assignment for immediate and future actions between the partners are core elements of Strategic Alliances. Balanced risk and profit settings of this model entitle both partners to define and benefit from long-term market success.

c‑LEcta contributes its assets to industry partnerships on specific project targets being initiated either through industry or c‑LEcta proposals. Within Project Partnerships, c-LEcta aligns with industry partners to jointly develop and commercialize biotechnological products for a clearly defined market, with balanced risks and profits according to the overall scope and partner contributions. Market implementation and commercialization usually remain under control of the industry partner. Often, the partners agree to market-side contributions by c‑LEcta, like contract manufacturing of the developed products.

We further offer our partners to benefit from c‑LEcta’s technology platforms and production capacity as a service. The Service model provides the sponsor with full control over the obtained results and their further use. Long-term options as extension of a basic fee for service model, like enzyme supply by c‑LEcta, or licensing of proprietary c‑LEcta technologies, may be implemented or outlined in an initial agreement of a contracted service.